Related Experiment Video
Updated: Jul 14, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine
Matthew J Hepburn1, E Hugh Dyson, Andrew J H Simpson
1Department of Biomedical Sciences, Defence Science and Technology Laboratory, Porton Down, Wiltshire, United Kingdom. mjhepburn@mail.dstl.gov.uk
Abstract:
A pilot study compared the immune response of regular (0, 3, 6, 32 weeks) and extended (0, 10, 13, 32 weeks) schedules of the UK anthrax vaccine (anthrax vaccine precipitated, AVP). Concentrations of antibodies to protective antigen (PA) were higher (p<0.05) among recipients of the extended (n=7) versus regular schedule (n=6) at week 32, and 2 weeks after the second and third vaccinations. Toxin neutralisation assay levels and anti-lethal factor antibodies followed patterns similar to anti-PA antibodies. Extending the interval between the first two AVP vaccinations may produce a stronger immune response, but persistence of this effect needs further study.
More Related Videos
Related Concept Videos
Vaccinations
Cross-reactivity
Inhalation Anthrax
Vaccines
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Allergic Reactions: Anaphylaxis

